PKI News and Press, PerkinElmer Inc. From 05/16/22

PerkinElmer has experienced significant growth over the past few years, admittedly with some of it being temporary because of the pandemic. This year should be weaker than last year was, but the overall fundamental condition for the enterprise is solid. Add in that shares look att...

PerkinElmer, Inc. (PKI) Q1 2022 Earnings Conference Call May 3, 2022 5:00 PM ET Company Participants Stephen Willoughby - Vice President of Investor Relations Prahlad Singh - President and Chief Executive Officer Jamey Mock - Senior Vice President and Chief Financial Officer Conference Call P...

PerkinElmer press release (NYSE:PKI): Q1 Non-GAAP EPS of $2.41 beats by $0.29. Revenue of $1.26B (-3.8% Y/Y) beats by $70M. Initiates Q2 and Raises 2022 Guidance: The Company forecasts revenue of approximately $1.20-1.22 billion which includes the recognition of approximately $100 millio...

First quarter revenue of $1.26 billion First quarter GAAP EPS from continuing operations of $1.40; Adjusted EPS of $2.41 Initiates Second Quarter and Raises Full Year Guidance PerkinElmer, Inc . (NYSE: PKI), a global leader committed to innovating for...

PerkinElmer (NYSE:PKI) is scheduled to announce Q1 earnings results on Tuesday, May 3rd, after market close. The consensus EPS Estimate is $2.12 (-43.0% Y/Y) and the consensus Revenue Estimate is $1.19B (-9.2% Y/Y). Over the last 2 years, PKI has beaten EPS estimates 100% of the time and has ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

As Danaher (DHR) is set to kick off the earnings season of the makers of Life Sciences & Diagnostic Tools on Thursday, Bank of America analysts led by Derik de Bruin issued cautious views on the subsector, citing macro and geopolitical headwinds. The earnings season for the group com...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

The U.S. FDA is warning that non-invasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when in actuality the fetus was healthy. The agency noted that these tests, which are also known as noninvasive prenatal tests (NIPT), ha...

Agilent looks fundamentally undervalued after losing 30% since its ATH. The company delivers consistently solid financial results and is forecasted to further increase its profitability. AI and machine learning will play a determinant role in the key markets of the company. Th...